biotech
Bio-AnalystSupplement research
person

Rhodiola

Cognition

Human studies reported between-group improvement in attention.

combination-ingredient studies · Individual ingredient effects cannot be separated · Human studies · between-group comparison

Publications for this result: 1

Other outcomes and study details

Distinct publications linked to this topic: 5

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
  • Combination, formula, or class studies do not isolate this ingredient or establish synergy.

What has been studied?

Distinct human comparison papers: 1

Some studies tested several ingredients together. Those results cannot show this ingredient’s separate effect or establish synergy.

  • attention

    • Comparison result:A better result than the comparison group was reported.
      General population · Combination study · Two hours after a single dose
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Ingredient combination
      • General population
      • Secondary outcome
      • Between-group comparison
      • Timepoint: Two hours after a single dose
      • Study comparison: 270 mg ADAPT-232 fixed combination versus placebo on d2 attention-test performance
  • Physical and cognitive deficiencies

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.
      Deficiency group · Combination study
      Measurement and study conditions
      • Other evidence
      • Clinical trial
      • Ingredient combination
      • Deficiency group
      • Outcome role not specified
      • Timepoint: unspecified
      • Study comparison: unspecified

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (3)
  • cognitive functions · Distinct papers needing additional review: 1Evidence criteria check: 1
  • cognitive performance · Distinct papers needing additional review: 1Direction unclear: 1
  • impaired cognition · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Exercise performance

    Related papers 12 · human comparison papers 4

    View results
    • jump height · Improvement reported · Some studies used more than one ingredient
    • power decline during high-frequency jumps · Improvement reported · Some studies used more than one ingredient

    More outcome groups: 13

  • Stress and mood

    Related papers 8 · human comparison papers 1

    View results
    • SDS · Mixed results · Some studies used more than one ingredient · Some studies included patients or people with a deficiency
    • HAM-D · Interpretation held

    More outcome groups: 3

  • Cognition

    Related papers 5 · human comparison papers 1

    View selected result
  • Fatigue and energy

    Related papers 4 · human comparison papers 1

    View results
    • Vitality-subscale · Worsening reported · Some studies included patients or people with a deficiency
    • 5 km run · Interpretation held

    More outcome groups: 7

  • Sleep

    Related papers 2 · comparison findings need further review

    View results
    • Insomnia symptoms · Interpretation held
  • Blood lipids

    Related papers 1 · comparison findings need further review

    View results
  • Glucose and metabolic health

    Related papers 1 · comparison findings need further review

    View results
    • plasma glucose · Interpretation held
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 60.9 evidence score includes 8 independent human studies and 8 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 92

Papers linked to this topic 5 · distinct papers 5 · papers with a confirmed human comparison 1 · papers needing additional review 3

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • attention: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • cognitive functions: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • cognitive performance: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • impaired cognition: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Physical and cognitive deficiencies: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

Exercise performance

What the research found

TTE

No clear difference in this measurement was found between the compared groups.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

jump height

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

power decline during high-frequency jumps

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

RPE scores

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

time to exhaustion

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Yo-Yo IR2 performance

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

performance fatigability

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

30 m sprint

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

5 km run

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

countermovement jump (CMJ)

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

maximal oxygen consumption (VO2max)

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

overall training performance

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

running and swimming times

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

standing long jump

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

time-to-exhaustion

The study needs further checking before its result can be interpreted.

Review · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

4 papers · 5 measured outcomes

4 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Stress and mood

What the research found

SDS

Results for this measurement were mixed; no consistent conclusion can be drawn.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

mean HARS scores

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

stress symptoms

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HAM-D

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

situational anxiety

The study needs further checking before its result can be interpreted.

Other evidence · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cognition

What the research found

attention

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Physical and cognitive deficiencies

A change was reported, but the comparison could not be confirmed.

Other evidence · Ingredient combination · Deficiency group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cognitive functions

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cognitive performance

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

impaired cognition

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fatigue and energy

What the research found

Vitality-subscale

The study reported worsening in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

mental fatigue

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

5 km run

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

heart rate 60 s after the simulated game

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

RPE score

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

total antioxidant capacity

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

total completion time in the simulated game

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

VO2max

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

YO-YO test

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Sleep

What the research found

ISI

The study needs further checking before its result can be interpreted.

Other evidence · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood lipids

What the research found

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Glucose and metabolic health

What the research found

plasma glucose

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
2
Findings from individual and combined use, plus reviewed cautions
Key precautions
No reviewed caution rules are available yet. Reported caution findings are shown below.
Review 1 combination findings and 0 findings that outperformed an ingredient alone.
These findings were reported in studies. They do not predict an individual's experience.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Cautions reported with another supplement or medication

These studies reported worsening outcomes, reduced absorption, or other cautions with combined use. They do not predict an individual's outcome.

SSRIsPotential risk of serotonin syndrome when combined with SSRIs.
Tricyclic antidepressantsPotential risk of serotonin syndrome when combined with tricyclic antidepressants.

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

CaffeineA randomized, double-blind, placebo-controlled trial in 48 male volleyball players found that combined Rhodiola rosea and caffeine supplementation significantly improved jump height, reduced power decline during high-frequency jumps, and lowered perceived exertion compared to placebo and single-agent groups.